trending Market Intelligence /marketintelligence/en/news-insights/trending/H4mn1H80M1HVDSq8dfKimA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Masimo noninvasive blood oxygen measurement device approved by US FDA

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Masimo noninvasive blood oxygen measurement device approved by US FDA

Masimo Corp. said the U.S. Food and Drug Administration cleared its Rad-67 device combined with the Spot-check Next Generation SpHb monitoring system and Rainbow DCI sensor to measure the oxygen level in the blood.

Rad-67 is a pulse oximeter, a noninvasive device that measures the fraction of oxygen-carrying hemoglobin to total hemoglobin in the blood. The device also measures methemoglobin, stable oxidized hemoglobin that cannot transfer oxygen to the body's tissues, and a complex of carbon monoxide and hemoglobin called carboxyhemoglobin.

The device also allows for a historical review of the collected data, patient identification and wireless data transfer to electronic medical records. According to the company's March 25 press release, Rad-67 cannot be used for pregnant and pediatric patients as well as those with kidney disease. The device is not a replacement for laboratory blood testing, Masimo said.

The Irvine, Calif.-based healthcare company develops and markets noninvasive monitoring technologies.